Atlas Trials

Advanced / Metastatic Solid Tumors

28 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced / Metastatic Solid Tumors

RecordFirmDate
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors (NCT05405595)Adagene Inc2022-06-15
ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors (NCT05277402)Adagene Inc2022-02-09
A Study of FDA018-ADC in Patients With Advanced Solid Tumors (NCT05174637)Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.2021-10-22
ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors (NCT04645069)Adagene Inc2021-03-15
A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients (NCT04501276)Adagene Inc2020-09-23
Study of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid Tumors (NCT04182516)Nerviano Medical Sciences2019-11-25
Study of Selumetinib (MK-5618) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (MK-5618-001) (NCT03833427)Merck Sharp & Dohme LLC2019-03-18
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors (NCT03526835)Merus B.V.2018-05-02
Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid Tumors (NCT02665416)Hoffmann-La Roche2016-01-25
A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors (NCT02444793)Pfizer2015-05-01
Study of NMS-1116354 in Advanced/Metastatic Solid Tumors (NCT01092052)Nerviano Medical Sciences2010-01-01
Dose-Escalation Study of PHA-793887 in Patients With Advanced/Metastatic Solid Tumors (NCT00996255)Nerviano Medical Sciences2006-11-01

Track Advanced / Metastatic Solid Tumors automatically

Every clearance here is in the API, with alerts when new ones post.